Management reiterated their guidance for $8 billion in free cash flow for 2025. CFO Neumann confirmed the company’s commitment to reinvesting in profitable growth and returning excess cash to ...

Netflix remains a 'Strong Buy' with growth in ad plans, global expansion, and robust retention rates. Read here for an ...

Genuine Parts Company thrives on tariffs, onshoring, and cost-saving tech, making GPC stock an attractive buy with strong ...

OPTZ, a unique all-cap ETF with GARP features. Low 14.77x P/E and high-growth potential, but higher risk. See more on OPTZ ...

Struggling with heavy debt, Clear Channel Outdoor faces challenges in the US advertising market amid financial losses & ...

AMD takes an $800M hit due to China's export rules. It has a higher reliance on China for overall revenues. Read an update on ...

Uber (UBER) outpaces the S&P 500 in 2025 with 21% YTD growth. See more on UBER's strong Q4 results, growth initiatives, and ...

Advanced Micro Devices, Inc. is the value pick amidst a selloff. With AI growth potential & undervalued, explore its rebound ...

The multi-week decline of the USD/JPY from the 28 March high of 151.21 has stalled today, supported by US President Trump’s ...

Granite Construction's revenue grew 14.2% in 2024, driven by acquisitions and higher sales prices. Click here to find out why ...

Persistent inflation and bond market volatility turned safe 40% in a 60-40 portfolio into risk. Check out three stocks to ...

By Diederik StadigUS President Donald Trump signed a new executive order on 15 April aimed at bringing US drug prices down.